Commercial Operations

Horizon Acquires U.S. Rights to Vimovo

Illinois-based drugmaker Horizon Pharma has acquired the U.S. rights to AstraZeneca’s Vimovo delayed-release tablets in order to bolster the company’s primary care portfolio. Rights outside the U.S. will be retained by AstraZeneca. Read More

Baxter and Cell Therapeutics Announce Strategic Partnership

Baxter International and Cell Therapeutics (CT) on Friday joined together in a strategic partnership to develop and market pacritinib, CT’s investigational JAK2/FLT3 inhibitor for genetic mutations connected to myelofibrosis, leukemia and other types of solid tumors. Read More

Drugmakers Need Drug Shortage Task Forces, EFPIA Says

Drugmakers should establish a company task force of upper management and quality personnel to prevent drug shortages, according to new good practice guidelines developed by the European Federation of Pharmaceutical Industries and Associations (EFPIA). Read More